Annual Scientific Conference
The Annual Scientific Conference provides an opportunity for graduate students and postdoctoral fellows to present their research progress to the faculty and their peers. In addition, the Conference is designed to acquaint new first year graduate students with the Program and to inform them of research opportunities. Faculty members have the opportunity to present at a poster session. Cancer Biology graduate students are required to attend the Conference.
Location: Fogarty Winery
Program Starts: Friday, November 12, 2021
Program Ends: Virtual, Saturday, November 13, 2021
Gunsagar Gulati, M.D., Ph.D.
Resident, Brigham and Women's Hospital Boston
Gunsagar S. Gulati received his undergraduate degree in Human Developmental and Regenerative Biology from Harvard College and his MD and PhD in Cancer Biology from Stanford University in the Weissman and Newman laboratories. He is currently a resident physician in the internal medicine program at Brigham and Women’s Hospital and will be short-tracking to fellowship in hematology and oncology. His research has focused on identifying new stem cell populations in normal and cancer tissues and developing computational tools to better understand and treat human tumors. Gunsagar identified new populations of hematopoietic and skeletal stem cells and developed CytoTRACE, a computational approach for predicting the developmental potential of single cells from transcriptional data. He aims to build his career at the intersection of stem cell and cancer biology, developing new approaches for identifying and targeting cancer stem cells. His ultimate goal is to lead an academic research group as a physician scientist who sees cancer patients in the clinic and studies their disease in the laboratory.
Kathryn Yost, Ph.D.
Postdoctoral Fellow, Johnathan Weissman Lab, Whitehead Institute, Boston
Katie Yost received her undergraduate degree in Biochemistry from Washington and Lee University and completed her Ph.D. in Cancer Biology at Stanford University in the lab of Howard Chang. She is currently a NCI K00 Postdoctoral Fellow in the lab of Jonathan Weissman at the Whitehead Institute in Cambridge, MA. Her research utilizes genomic technologies and functional perturbations to better understand cellular and regulatory dynamics in cancer progression and response to therapy. Katie discovered that the T cell response to PD-1 blockade consists of novel T cell clones not previously observed in the same tumor, a process termed clonal replacement. Further, she found that extrachromosomal DNA clusters in the nucleus of interphase cancer cells to promote intermolecular enhancer-promoter interactions and high levels of oncogene expression. Her long-term goal is to decode the dynamic interactions between cancer and the immune system and to perturb these systems to gain novel insights into the biological processes that underlie cancer progression and therapeutic response.
2021 Cancer Biology Retreat Winners
- King Hung
- Monica Nesselbush
- Jason Rodencal
- Fernanda Gonzalez
- Lindsey Mehl
- Kiarash Shamardani
- Alan Tung